Tag Archives: Adult

The Many Factors That Make a Child’s Well-Being Build Our Adult Health – the Aspirational OECD Framework

The ultimate health and wellbeing of an adult depends on the factors that shape us when we are children. A new, deep report from the OECD, Measuring What Matters for Child Well-being and Policies, spells out the many domains of experience that, together, bolster our whole health as we grow from child to adult. The first… Read More »

Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More »

FDA Approves Sevenfact [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors

FDA Approves Sevenfact [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors Print this page LOUISVILLE, Ky., April 6, 2020 /PRNewswire/ — HEMA Biologics, LLC, (“HEMA Biologics”) today announced that the U.S. Food and Drug Administration (FDA) approved Sevenfact® [coagulation factor… Read More »

The Heavier the Baby, the Fitter the Young Adult?

Higher birth weight may predict better cardiovascular fitness in adulthood, researchers report. Scientists measured fitness in 286,761 Swedish men ages 17 to 25 by having them ride a bicycle ergometer and recording the wattage they were able to generate. They used data on birth weights from the Swedish Medical Birth Registry. They found that as… Read More »

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients Print this page December 23, 2019 — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for its in-house discovered and developed orexin receptor antagonist Dayvigo (lemborexant). Dayvigo… Read More »

Adult acne: Understanding underlying causes and banishing breakouts – Harvard Health Blog – Harvard Health

“I’m not a teenager anymore, why do I still have acne?!” This is a question we hear from patients on a daily basis. The truth is, it is quite common to see acne persist into adulthood. Although acne is commonly thought of as a problem of adolescence, it can occur in people of all ages.… Read More »